Evaluation of real-time quantitative PCR for NPM1 mutations to detect minimal residual disease and predict relapse in acute myeloid leukaemia.

Project: Research

Project Details

StatusFinished
Effective start/end date1/02/200831/12/2013

Funding

  • Blood Cancer UK: £288,916.00